As mentioned before a SPRTN deficiency has been linked with a new progeroid syndrome with propensity to develop early onset hepatocellular carcinomas, but it is still not clear whether this phenotype is directly linked with its proposed control of polη (Lessel et al., 2014). This evidence concerns the gene SPRTN and hepatocellular carcinoma.